Subscription Allocation. The Company is offering to each registered holder (each a “Shareholder”) of shares of Company common stock, no par value (“Shares”) the opportunity to subscribe to and purchase their respective pro rata percentage (“Allocation”) of a total of 7,370,609 Shares (the “Subscription Shares”) at a price of $1.54 per Share (the “Subscription Price”). A Shareholder’s Allocation shall be the total number of Subscription Shares multiplied by the percentage determined by dividing (A) the total number of Shares owned of record by the Shareholder immediately before the Subscription Offer, by (B) the total number of Shares owned by all Shareholders in the aggregate immediately before the Subscription Offer. BioTime, Inc. 73.56% 5,421,714
Appears in 2 contracts
Sources: Stock Subscription Agreement (OncoCyte Corp), Stock Subscription Agreement (OncoCyte Corp)
Subscription Allocation. The Company is offering to each registered holder (each a “Shareholder”) of shares of Company common stock, no par value (“Shares”) the opportunity to subscribe to and purchase their respective pro rata percentage (“Allocation”) of a total of 7,370,609 Shares (the “Subscription Shares”) at a price of $1.54 per Share (the “Subscription Price”). A Shareholder’s Allocation shall be the total number of Subscription Shares multiplied by the percentage determined by dividing (A) the total number of Shares owned of record by the Shareholder immediately before the Subscription Offer, by (B) the total number of Shares owned by all Shareholders in the aggregate immediately before the Subscription Offer. BioTime, Inc. 73.56% 5,421,714.
Appears in 1 contract